The etiological diagnosis of "Primary" hypophysitis requires prolonged follow-up: a case of Langerhans cell histiocytosis [0.03%]
原发性垂体炎的病因诊断需要长期随访：一例朗格汉斯细胞组织细胞增生症病例报告
Léa Miquel,Nicolas Sahakian,Benoit Testud et al.
Léa Miquel et al.
Jonanlis Ramirez Alcantara,Natalie R Grant,Takara Stanley et al.
Jonanlis Ramirez Alcantara et al.
Introduction: Hypogonadism has been reported in patients with X-linked adrenoleukodystrophy (ALD), but little is known about prevalence and characteristics. We aimed to further characterize hypogonadism in males with ALD....
Geneviève Sassolas
Geneviève Sassolas
Prognostic Factors and Survival in Gastroenteropancreatic Neuroendocrine Neoplasm: Real-World Evidence from a South American Single-Center Cohort [0.03%]
胃肠道胰神经内分泌肿瘤的预后因素和生存率：南美单中心真实世界证据
Luisana Molina-Pimienta,Andrés A Cuéllar Cuéllar,Mireya Tapiero-García et al.
Luisana Molina-Pimienta et al.
Background: Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is a rare tumor, but with increasing global prevalence. However, data on epidemiology and survival in Latin America are sparse. ...
Assessment of diagnostic cutoff for anti-glutamic acid decarboxylase autoantibodies (GADA) measured by a commercial radiobinding assay [0.03%]
商业放射结合试验测定抗谷氨酸脱羧酶自身抗体(GADA)诊断切点的评价
Romain Vankemmel,Aurore Declomesnil,Madleen Lemaitre et al.
Romain Vankemmel et al.
Background: Using the manufacturer's suggested cutoff values for anti-glutamic acid decarboxylase antibodies (GADA) results in intermediate levels (1-2 U/mL) in which the patient's status is unclear. Our aim was to re-eva...
Rare Causes of Pediatric Primary Adrenal Insufficiency: Data from a Large Nationwide Tunisian Cohort [0.03%]
Tunisia全国范围内大型儿童原发性肾上腺皮质功能减退罕见原因队列的数据分析
Rania Khalfallah,Fakhri Kallabi,Delphine Mallet et al.
Rania Khalfallah et al.
Context: Primary adrenal insufficiency (PAI), a rare and potentially life-threatening disorder, involves genetic factors in over 80% of pediatric cases. Congenital adrenal hyperplasia (CAH) is common, while the prevalence...
Erratum to "The thyroid hormone system and its disruption" [Ann. Endocrinol. (Paris) (2025) 101773] [0.03%]
“甲状腺激素系统及其紊乱”一文的勘误(巴黎，2025年，101773)
Anni Herranen,Patricia Rannaud-Bartaire,Jean-Baptiste Fini
Anni Herranen
Published Erratum
Annales d'endocrinologie. 2025 Oct 6;86(5):102433. DOI:10.1016/j.ando.2025.102433 2025
Marie-Christine Vantyghem,Vincent Prévot,Maria-Christina Zennaro et al.
Marie-Christine Vantyghem et al.
Epidemiologic and clinical aspects of congenital hypothyroidism in Côte d'Ivoire, a country without systematic screening at birth [0.03%]
科特迪瓦地方性先天性甲状腺功能减退的流行病学和临床特点（该国没有系统性的新生儿筛查）
A Yao,M Kouamé,A N&#x;guessan et al.
A Yao et al.
Prolonged response to lenvatinib in a poorly differentiated thyroid carcinoma with leptomeningeal carcinomatosis [0.03%]
仑伐替尼治疗分化差的甲状腺癌和脑膜转移的持久反应
Christophe Sajous,Helene Lasolle,Myriam Decaussin-Petrucci et al.
Christophe Sajous et al.